Marketing Jobs
Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide.
What is it that defines Celgene? Most fundamentally, Celgene is its employees, who are focused on the mission of delivering innovative therapies to patients with unmet medical needs in cancer and inflammatory diseases. They are a varied group of talented people united in their commitment to discover, develop and market life-enhancing drugs that make a measurable difference in the lives of millions of people.
Why Apply for Marketing Jobs with Celgene?
If you would like to join the team and build on the Company's scientific and commercial achievements, apply for a Marketing Job with Celgene today. Our goal is to attract the best people at every level of the organization, and you can help us achieve that goal!
Not ready to apply today? Subscribe to our talent community below and we will email you as new jobs are added.
| Title | Location | Date![]() |
|---|---|---|
| Senior Manager, Global Market Insights Job | Summit, NJ, US | May 12, 2012 |
| Director, Oncology Cross-Franchise Initiatives and Strategic Marketing Job | Summit, NJ, US | May 10, 2012 |
| Associate Director, Global Business Planning and Analysis Job | Summit, NJ, US | May 10, 2012 |
| Marketing, Project Manager Job | Summit, NJ, US | May 10, 2012 |
| Commercial Director - Mexico Job | May 8, 2012 | |
| Business Analyst - (12 Month Contract) Job | Mississauga Ontario, Canada | May 4, 2012 |
| Director, Global Marketing Multiple Myeloma Job | Summit, NJ, US | May 3, 2012 |
| Commercial Director - Brazil Job | May 3, 2012 | |
| Associate Director Pricing and Market Access Job | Summit, NJ, US | May 3, 2012 |
| Associate Director Pricing and Market Access Job | Berkeley Heights, NJ, US | May 3, 2012 |
| Associate Director Pricing and Market Access Job | Summit, NJ, US | May 3, 2012 |
| Associate Director, Pricing and Market Access Job | Summit, NJ, US | Apr 27, 2012 |
| Director of US Health Policy and Reimbursement Job | Summit, NJ, US | Apr 20, 2012 |
